Senior insider sale
Chief Scientific Officer at CYTEIR THERAPEUTICS, INC. — senior position signals high conviction
$23.2K
13.18K shares
What this filing means
SECRIST JOHN PAUL plans to sell 13.18K shares of CYTEIR THERAPEUTICS, INC. valued at approximately $23.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/28/2023ACC: 0001972362-23-000439
Officer· Chief Scientific Officer
Since Jun 2021
13.18K
Shares to sell
$23.2K
Approx. market value
13.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
6/28/2023
13.18KTotal acquired13.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/28/2023 | STOCK OPTION EXERCISE COMPENSATION | 13.18K | — |
| Total | 13.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.18K
Market value
$23.2K
6/28/2023
Total
Units
13.18K
Value
$23.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/28/2023 | 13.18K | $23.2K | NASDAQ | Planned |
| Total | 13.18K | $23.2K | ||